Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Nucala Market Report 2025

Nucala Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Severe Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Chronic Obstructive Pulmonary Disease (COPD), Other Eosinophilic Disorders), By Distribution Channel (Direct Sales, Retail Pharmacies, Online Pharmacies), By End User (Hospitals, Clinics, Home Care Settings)

Nucala Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Nucala Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Nucala Market Definition

Nucala (mepolizumab) is a monoclonal antibody biologic therapy that targets and inhibits interleukin-5 (IL-5), a key cytokine involved in the growth, activation, and survival of eosinophils. By reducing eosinophilic inflammation, it helps manage symptoms and reduce the frequency of exacerbations in patients with severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis (EGPA), and other eosinophil-driven conditions.

The main types of indications for nucala are severe asthma, eosinophilic granulomatosis with polyangiitis (EGPA), chronic obstructive pulmonary disease (COPD), and other eosinophilic disorders. Severe asthma is a form of asthma that is difficult to control, requires higher medication doses, and is characterized by persistent symptoms like wheezing and breathlessness despite standard treatments. It is distributed through various channels such as direct sales, retail pharmacies, and online pharmacies and is used by various end users including hospitals, clinics, and home care settings.

Nucala Market Segmentation

The nucala market covered in this report is segmented –

1) By Indication: Severe Asthma; Eosinophilic Granulomatosis With Polyangiitis (EGPA); Chronic Obstructive Pulmonary Disease (COPD); Other Eosinophilic Disorders

2) By Distribution Channel: Direct Sales; Retail Pharmacies; Online Pharmacies

3) By End User: Hospitals; Clinics; Home Care Settings

Nucala Market Size and growth rate 2025 to 2029: Graph

Nucala Market Size 2025 And Growth Rate

The nucala market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growing awareness of severe asthma among patients, increasing adoption of biologics, expanding patient awareness, increasing healthcare expenditure, and expanding regulatory approvals.

Nucala Market Growth Forecast

The nucala market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising prevalence of asthma and chronic obstructive pulmonary disease (COPD), growing focus on precision medicine in treating allergic conditions, growing adoption of biologic therapies, increasing healthcare infrastructure, and expanding reimbursement coverage for biologics. Major trends in the forecast period include advancements in targeted therapies, advancements in drug development, technological advancements in biologics, advancements in drug delivery systems, and advancements in combination therapies.

Book your 30 minutes free consultation with our research experts

Contact Us

Nucala Market Driver: Growing Asthma Prevalence Fuels Market Growth

The increasing prevalence of asthma is expected to propel the growth of the nucala market going forward. Asthma is a chronic respiratory condition causing airway inflammation and narrowing, leading to symptoms such as wheezing, coughing, chest tightness, and shortness of breath, often triggered by allergens or physical activity. The increase in the prevalence of asthma is attributed to factors such as environmental pollution, allergens, changes in lifestyle, urbanization, and genetic predisposition. Nucala works to reduce asthma by targeting and inhibiting interleukin-5 (IL-5), a key protein involved in the growth and activation of eosinophils, which are white blood cells that contribute to airway inflammation in asthma, thereby reducing symptoms and the frequency of asthma exacerbations. For instance, in November 2023, according to the National Asthma Council, an Australia-based non-profit organization, in 2022, Australia recorded 467 asthma-related deaths, comprising 299 females and 168 males, an increase from 355 deaths in 2021. Therefore, the increasing prevalence of asthma is driving growth in the nucala market.

Nucala Market Driver: Growing Prevalence Of Eosinophilic Disorders To Drive Market Growth

The increasing prevalence of eosinophilic disorders is expected to propel the growth of the nucala market going forward. Eosinophilic disorders refer to a group of medical conditions characterized by the overproduction and accumulation of eosinophils, a type of white blood cell, in various tissues, leading to inflammation and potential damage. The increasing prevalence of eosinophilic disorders is attributed to factors such as rising environmental allergens, changes in dietary habits, genetic predispositions, and heightened awareness leading to improved diagnostic rates. Nucala (mepolizumab) treats eosinophilic disorders by targeting and inhibiting interleukin-5 (IL-5), a cytokine responsible for the growth and survival of eosinophils, thereby reducing eosinophil levels and alleviating associated symptoms. For instance, in October 2024, according to the American Gastroenterological Association, a US-based non-profit organization, the prevalence of eosinophilic esophagitis (EoE) has been rising, affecting 1 in 617 individuals under the age of 65 in 2022. The annual costs associated with EoE were projected to reach $1.3 billion in 2024, adjusted for inflation. Therefore, the increasing prevalence of eosinophilic disorders is driving growth in the nucala market.

Global Nucala Market Major Players

Major companies operating in the nucala market are GlaxoSmithKline plc

Global Nucala Market Trend: Development Of Ready-To-Use Injectable Formulations In The Market

The key trend in the nucala market is focused on developing innovative formulations, such as ready-to-use injectable forms, to enhance patient convenience and improve treatment adherence. A ready-to-use injectable form refers to a pharmaceutical product that is pre-prepared and requires no further dilution or mixing before administration. For instance, in January 2022, GlaxoSmithKline Plc, a UK-based pharmaceutical industry company, received US Food and Drug Administration (FDA) approval for a 40 mg prefilled syringe of Nucala (mepolizumab). The 40 mg prefilled syringe of Nucala (mepolizumab) is a ready-to-use injectable treatment for children aged 6-11 with severe eosinophilic asthma. It allows for convenient at-home administration after caregiver training by a healthcare provider.

Regional Analysis For The Global Nucala Market

North America was the largest region in the nucala market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucala market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nucala market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Nucala Market?

The nucala market consists of sales of nucala 100mg injections. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Nucala Industry?

The nucala market research report is one of a series of new reports from The Business Research Company that provides nucala market statistics, including the nucala industry global market size, regional shares, competitors with the nucala market share, detailed nucala market segments, market trends, and opportunities, and any further data you may need to thrive in the nucala industry. This nucala market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

    Table Of Contents

    1. Executive Summary

    2. Nucala Market Characteristics

    3. Nucala Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Nucala Market Trends And Strategies

    5. Nucala Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Nucala Growth Analysis And Strategic Analysis Framework

    6.1. Global Nucala PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Nucala Market Growth Rate Analysis

    6.4. Global Nucala Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Nucala Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Nucala Total Addressable Market (TAM)

    7. Global Nucala Pricing Analysis & Forecasts

    8. Nucala Market Segmentation

    8.1. Global Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Severe Asthma

    Eosinophilic Granulomatosis With Polyangiitis (EGPA)

    Chronic Obstructive Pulmonary Disease (COPD)

    Other Eosinophilic Disorders

    8.2. Global Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Direct Sales

    Retail Pharmacies

    Online Pharmacies

    8.3. Global Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Clinics

    Home Care Settings

    9. Global Nucala Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Nucala Market Regional And Country Analysis

    10.1. Global Nucala Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Nucala Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Nucala Market

    11.1. Asia-Pacific Nucala Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Nucala Market

    12.1. China Nucala Market Overview

    12.2. China Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Nucala Market

    13.1. India Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Nucala Market

    14.1. Japan Nucala Market Overview

    14.2. Japan Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Nucala Market

    15.1. Australia Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Nucala Market

    16.1. South Korea Nucala Market Overview

    16.2. South Korea Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Nucala Market

    17.1. Western Europe Nucala Market Overview

    17.2. Western Europe Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Nucala Market

    18.1. UK Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Nucala Market

    19.1. Germany Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Nucala Market

    20.1. France Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Nucala Market

    21.1. Eastern Europe Nucala Market Overview

    21.2. Eastern Europe Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Nucala Market

    22.1. North America Nucala Market Overview

    22.2. North America Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Nucala Market

    23.1. USA Nucala Market Overview

    23.2. USA Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Nucala Market

    24.1. Canada Nucala Market Overview

    24.2. Canada Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Nucala Market

    25.1. South America Nucala Market Overview

    25.2. South America Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Nucala Market

    26.1. Middle East Nucala Market Overview

    26.2. Middle East Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Nucala Market

    27.1. Africa Nucala Market Overview

    27.2. Africa Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Nucala Market Competitive Landscape And Company Profiles

    28.1. Nucala Market Competitive Landscape

    28.2. Nucala Market Company Profiles

    28.2.1. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis

    29. Global Nucala Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Nucala Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Nucala Market

    32. Recent Developments In The Nucala Market

    33. Nucala Market High Potential Countries, Segments and Strategies

    33.1 Nucala Market In 2029 - Countries Offering Most New Opportunities

    33.2 Nucala Market In 2029 - Segments Offering Most New Opportunities

    33.3 Nucala Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Nucala Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Nucala Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Asia-Pacific, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: China, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: India, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: Japan, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Australia, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: South Korea, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: Western Europe, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: UK, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: Germany, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: France, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: Eastern Europe, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: North America, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: USA, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: Canada, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: South America, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: Middle East, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Africa, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: GlaxoSmithKline plc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Nucala Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Nucala Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Asia-Pacific, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: China, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: India, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: Japan, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Australia, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: South Korea, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: Western Europe, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: UK, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: Germany, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: France, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: Eastern Europe, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: North America, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: USA, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: Canada, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: South America, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: Middle East, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Africa, Nucala Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Nucala Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Nucala Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: GlaxoSmithKline plc. Financial Performance

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

What Is The Pharmaceutical Processing Seals Market Overview In 2022?

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Latest Digestive Health Supplements Market Growth Study 2022-2026 By The Business Research Company

Read More

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the pegfilgrastim biosimilars market market research report 2022 with industry size, share, segments and market growth

Read More

Drug Delivery Devices Market 2021 - By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Eyewear Global Market Report 2025 – By Product (Contact Lenses, Spectacles, Sunglasses), By Gender (Men, Women, Unisex), By Distribution Channel (Optical Stores, Independent Brand Showrooms, Online Stores, Retail Stores) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Application Testing Services Global Market Report 2025 – By Testing Type (Functionality Testing, Usability Testing, Performance Testing, Compatibility Testing, Security Testing, Compliance Testing, Automation Testing, Other Testing Types), By Organization Size (Small and Medium Enterprises, Large Enterprises), By Service Type (Professional Services, Managed Services), By Delivery Model (Onshore, Offshore, Nearshore, Onsite), By Vertical (Telecom and IT, BFSI, Healthcare and Life Sciences, Government and Public Sector, Media and Entertainment, Manufacturing, Retail, Energy and Utilities, Logistics and Transportation, Other Verticals) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Other Basic Inorganic Chemical Global Market Report 2025 – By Product Type (Basic Inorganic Chemicals, Alkali Chemicals), By Application (Concentrators, Separators, Condensers, Vaporizers, Reactor vessels, Other Applications), By Industry (Food Industry, Pharmaceuticals, Personal Care, Agriculture, Other Industries) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anti-Asthmatics And COPD Drugs Global Market Report 2025 – By Drug Class (Bronchodilators, Anti-Inflammatory Drugs, Monoclonal Antibodies, Combination Drugs), By Distribution Channel (Hospital Pharmacies, General Pharmacies, Online Retailers), By End User (Asthma Patients, COPD Patients), By Therapy (Preventive, Curative), By Route Of Administration (Oral, Inhaled, Intravenous, Subcutaneous), By Age Group (Below 5, 5-14, 15-60, Above 60) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Medical Device Reprocessing Global Market Report 2025 – By Type (Reprocessing support and Services, Reprocessing Medical Devices), By Device Category (Critical Devices, Semi-Critical Devices, Non-Critical Devices), By Application (Cardiology, Gastroenterology, Gynecology, Orthopedic, General Surgery, Other Applications), By End-Use (Hospital, Ambulatory Service Centers, Home Healthcare) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Nasal Splints Global Market Report 2025 – By Type (Malleable Nasal Splints, Airway Nasal Splints, Bivalve Nasal Splints,), By Route of Administration (Intranasal Segment, Extranasal Segment), By Application (Plastic Surgery, Rhinological operations, ENT-Surgery, Other Applications), By End User (Hospitals & Clinics, Homecare, Research Centers, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (General Pharmacies, Hospital Pharmacies, Online Retailers), By Therapy (Preventive, Curative), By Route Of Administration (Oral, Inhaled, Intravenous, Subcutaneous), By Age Group (Below 5, 5-14, 15-60, Above 60), By Prescription (Prescription, Over The Counter (OTC)), By Drug Type (Branded, Generic) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Nucala market?

Nucala (mepolizumab) is a monoclonal antibody biologic therapy that targets and inhibits interleukin-5 (IL-5), a key cytokine involved in the growth, activation, and survival of eosinophils. By reducing eosinophilic inflammation, it helps manage symptoms and reduce the frequency of exacerbations in patients with severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis (EGPA), and other eosinophil-driven conditions. For further insights on the Nucala market, request a sample here

How will the Nucala market drivers and restraints affect the market dynamics? What forces will shape the Nucala industry going forward?

The Nucala market major growth driver - Growing Asthma Prevalence Fuels Market Growth. For further insights on the Nucala market, request a sample here

What is the forecast market size or the forecast market value of the Nucala market?

The Nucala market size has grown strongly in recent years. The nucala market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to growing awareness of severe asthma among patients, increasing adoption of biologics, expanding patient awareness, increasing healthcare expenditure, and expanding regulatory approvals. The nucala market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising prevalence of asthma and chronic obstructive pulmonary disease (COPD), growing focus on precision medicine in treating allergic conditions, growing adoption of biologic therapies, increasing healthcare infrastructure, and expanding reimbursement coverage for biologics. Major trends in the forecast period include advancements in targeted therapies, advancements in drug development, technological advancements in biologics, advancements in drug delivery systems, and advancements in combination therapies. For further insights on the Nucala market, request a sample here

How is the Nucala market segmented?

The nucala market covered in this report is segmented –
1) By Indication: Severe Asthma; Eosinophilic Granulomatosis With Polyangiitis (EGPA); Chronic Obstructive Pulmonary Disease (COPD); Other Eosinophilic Disorders
2) By Distribution Channel: Direct Sales; Retail Pharmacies; Online Pharmacies
3) By End User: Hospitals; Clinics; Home Care Settings For further insights on the Nucala market, request a sample here

Which region has the largest share of the Nucala market? What are the other regions covered in the report?

North America was the largest region in the nucala market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucala market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Nucala market, request a sample here.

Who are the major players in the Nucala market?

Major companies operating in the nucala market are GlaxoSmithKline plc . For further insights on the Nucala market, request a sample here.

What are the key trends in the Nucala market?

Major trends in the Nucala market include Development Of Ready-To-Use Injectable Formulations In The Market. For further insights on the Nucala market, request a sample here.

What are the major opportunities in the Nucala market? What are the strategies for the Nucala market?

For detailed insights on the major opportunities and strategies in the Nucala market, request a sample here.

How does the Nucala market relate to the overall economy and other similar markets?

For detailed insights on Nucala's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Nucala industry?

For detailed insights on the mergers and acquisitions in the Nucala industry, request a sample here.

What are the key dynamics influencing the Nucala market growth? SWOT analysis of the Nucala market.

For detailed insights on the key dynamics influencing the Nucala market growth and SWOT analysis of the Nucala industry, request a sample here.